[go: up one dir, main page]

AU1681100A - Betacellulin modification - Google Patents

Betacellulin modification

Info

Publication number
AU1681100A
AU1681100A AU16811/00A AU1681100A AU1681100A AU 1681100 A AU1681100 A AU 1681100A AU 16811/00 A AU16811/00 A AU 16811/00A AU 1681100 A AU1681100 A AU 1681100A AU 1681100 A AU1681100 A AU 1681100A
Authority
AU
Australia
Prior art keywords
betacellulin
modification
activity
antigenicity
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16811/00A
Inventor
Koichi Igarashi
Takashi Ito
Masayuki Kobayashi
Mitsuyo Kondo
Osamu Nishimura
Reiko Sasada
Yoko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU1681100A publication Critical patent/AU1681100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The betacellulin mutein or its salt of the present invention is useful for better therapeutic drug for diabetes, since they have intact BTC activity and reduced EGF activity, and no antigenicity-related problems.
AU16811/00A 1998-12-09 1999-12-08 Betacellulin modification Abandoned AU1681100A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP35037798 1998-12-09
JP10/350377 1998-12-09
JP11/55326 1999-03-03
JP5532699 1999-03-03
PCT/JP1999/006873 WO2000034478A1 (en) 1998-12-09 1999-12-08 Betacellulin modification

Publications (1)

Publication Number Publication Date
AU1681100A true AU1681100A (en) 2000-06-26

Family

ID=26396224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16811/00A Abandoned AU1681100A (en) 1998-12-09 1999-12-08 Betacellulin modification

Country Status (11)

Country Link
US (1) US6825165B1 (en)
EP (1) EP1148129B1 (en)
AT (1) ATE368111T1 (en)
AU (1) AU1681100A (en)
CA (1) CA2353909C (en)
CY (1) CY1106882T1 (en)
DE (1) DE69936666T2 (en)
DK (1) DK1148129T3 (en)
ES (1) ES2288034T3 (en)
PT (1) PT1148129E (en)
WO (1) WO2000034478A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509093A (en) * 2004-08-06 2008-03-27 ノヴォザイムズ グロペップ リミテッド Diabetes treatment
JP2008545715A (en) * 2005-05-27 2008-12-18 ファイブ プライム セラピューティクス， インコーポレイテッド Methods and compositions for stimulating glucose uptake into muscle cells and methods and compositions for treating diseases
MX2023000547A (en) 2020-07-16 2023-02-13 Novartis Ag ANTI-BETACELLULIN ANTIBODIES, FRAGMENTS THEREOF, AND MULTI-SPECIFIC BINDING MOLECULES.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69306273T2 (en) 1992-02-10 1997-04-03 Childrens Medical Center Mitogen for smooth muscles and its coding DNA
US6410506B1 (en) * 1995-05-19 2002-06-25 Human Genome Sciences, Inc. Transforming growth factor α HII
EP0862451B1 (en) 1995-11-09 2003-01-29 Takeda Chemical Industries, Ltd. Composition for improving pancreatic function
JPH10191989A (en) * 1996-11-12 1998-07-28 Takeda Chem Ind Ltd Production of betacellulin compounds

Also Published As

Publication number Publication date
US6825165B1 (en) 2004-11-30
ES2288034T3 (en) 2007-12-16
EP1148129A4 (en) 2005-06-22
ATE368111T1 (en) 2007-08-15
DK1148129T3 (en) 2007-10-15
CA2353909A1 (en) 2000-06-15
CY1106882T1 (en) 2012-09-26
DE69936666D1 (en) 2007-09-06
EP1148129B1 (en) 2007-07-25
CA2353909C (en) 2009-07-07
EP1148129A1 (en) 2001-10-24
PT1148129E (en) 2007-09-05
WO2000034478A1 (en) 2000-06-15
DE69936666T2 (en) 2008-05-21

Similar Documents

Publication Publication Date Title
AU1642795A (en) Substituted pyridylpyrazoles
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU650727B2 (en) Biomedical electrode having centrally-positioned tab construction
AU5022593A (en) Prodrugs, their preparation and use as pharmaceuticals
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
AU1450900A (en) Methods of treatment of type 2 diabetes
AU5485698A (en) Oxyiminopregnancarbolactone
AUPO811797A0 (en) Tropoelastin derivatives
WO1997003188A3 (en) Use of mp52 or mp121 for treating and preventing diseases of the nervous system
AUPP105497A0 (en) Aqueous insecticidal pour-on treatment
AU1576999A (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
CY1106882T1 (en) MODIFICATION OF BITACELLARINE
AU7595298A (en) Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension
AU4984200A (en) Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
WO1998059005A3 (en) Use of polycarbonates containing iodine phenyl carbonate for producing special shaped parts
AU1174588A (en) Anticonvulsant agents
AU6309398A (en) Agent for preventing and/or treating cachexia
AU8127898A (en) Pyridyltriazole compounds, processes for producing the same and agricultural andhorticultural germicides
AU664101B2 (en) Novel phospholipid derivatives
AU9797598A (en) Treatment of diabetic retinopathy
AU4107797A (en) Compounds for the treatment and prevention of diabetes
AU3744100A (en) Bicyclo(3.3.1)nonenes useful for the treatment of diabetes
ZA983753B (en) Medicinal composition for treatment of burns, cuts and like wounds.
EP0895783A3 (en) Pharmaceutical composition comprising ifosfamide and carnitine
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase